Remdesivir for COVID-19: Why not dose higher?

Victoria C. Yan, Florian L. Muller

Research output: Contribution to journalLetterpeer-review

6 Scopus citations
Original languageEnglish (US)
Article numbere02713-20
JournalAntimicrobial agents and chemotherapy
Volume65
Issue number4
DOIs
StatePublished - Apr 2021

Keywords

  • COVID-19
  • Drug metabolism
  • GS-441524
  • Prodrug
  • Remdesivir

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Cite this